Inventor · disambiguated record
Mark Munson
Also filed as: MUNSON MARK · MUNSON MARK C
27 granted patents·19 pending applications·731 citations·filing 2003–2025
96Inventor score
Top patents by PatentIndex Score
46 records- 0196US7799782B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 21, 2010·600 cites·23 claims
- 0292US9321786B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Apr 26, 2016·15 cites·51 claims
- 0389US7135575B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2003·Granted Nov 14, 2006·29 cites·16 claims
- 0488US9663524B2Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitorsCELGENE CAR LLC·Filed 2014·Granted May 30, 2017·15 cites·27 claims
- 0587US9695132B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jul 4, 2017·5 cites·63 claims
- 0685US7521447B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Apr 21, 2009·28 cites·33 claims
- 0783US8044083B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 0881US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 0980US10189794B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2017·Granted Jan 29, 2019·2 cites·56 claims
- 1079US8039639B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Granted Oct 18, 2011·4 cites·1 claims
- 1177US10065966B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2017·Granted Sep 4, 2018·2 cites·27 claims
- 1277US8138181B2Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitorsALLEN SHELLEY·Filed 2008·Granted Mar 20, 2012·3 cites·29 claims
- 1375US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 1474US8557809B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Oct 15, 2013·2 cites·17 claims
- 1574US8026233B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Sep 27, 2011·2 cites·19 claims
- 1673US8017641B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 13, 2011·1 cites·10 claims
- 1772US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 1871US10774052B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2019·Granted Sep 15, 2020·0 cites·31 claims
- 1971US8575145B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Nov 5, 2013·2 cites·29 claims
- 2071US8518983B2P38 inhibitors and methods of use thereofMUNSON MARK·Filed 2009·Granted Aug 27, 2013·2 cites·8 claims
- 2171US8202899B2Pyrazole urea derivatives used as kinase inhibitorsMUNSON MARK C·Filed 2008·Granted Jun 19, 2012·4 cites·6 claims
- 2271US2022332687A1Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2020·Application pending·0 cites
- 2368US2025197422A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2467US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 2565US2024279220A1Indole compounds and methods of useGENZYME CORP·Filed 2024·Application pending·0 cites
- 2664US2024239784A1Indole compounds and methods of useGENZYME CORP·Filed 2024·Application pending·0 cites
- 2762US10618902B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2018·Granted Apr 14, 2020·0 cites·15 claims
- 2862US8841455B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitorsBOYS MARK LAURENCE·Filed 2010·Granted Sep 23, 2014·1 cites·41 claims
- 2957US2025326749A1Compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3056US2016152576A9Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 3155US2005130954A1AKT protein kinase inhibitorsFiled 2004·Application pending·0 cites
- 3255US2023147360A1Arylamides and methods of use thereofGENZYME CORP·Filed 2022·Application pending·0 cites
- 3355US2004180896A1P38 inhibitors and methods of use thereofFiled 2003·Application pending·0 cites
- 3454US2023159439A1Arylamides and methods of use thereofGENZYME CORP·Filed 2022·Application pending·0 cites
- 3553US2023348454A1Compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell diseaseGENZYME CORP·Filed 2021·Application pending·0 cites
- 3653US2023348450A1Carboxylic acid-containing compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell diseaseGENZYME CORP·Filed 2021·Application pending·0 cites
- 3753US2024002374A15-membered heteroarylaminosulfonamides for treating conditions mediated by deficient cftr activityGENZYME CORP·Filed 2022·Application pending·0 cites
- 3852US2023159438A1Arylamides and methods of use thereofGENZYME CORP·Filed 2022·Application pending·0 cites
- 3950US8895550B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 25, 2014·0 cites·22 claims
- 4049US2025248975A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4149US2025197420A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4248US2010144751A1IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORSARRAY BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 4346US11098056B2UDP glycosyltransferase inhibitors and methods of useGENZYME CORP·Filed 2019·Granted Aug 24, 2021·0 cites·30 claims
- 4446US2006264431A1P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Application pending·0 cites
- 4544US8987251B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Mar 24, 2015·0 cites·33 claims
- 4641US2014228349A15,7-substituted-imidazo[1,2-c]pyrimidinesARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Munson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →